1512 related articles for article (PubMed ID: 25872541)
1. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN
Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
[TBL] [Abstract][Full Text] [Related]
2. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
[TBL] [Abstract][Full Text] [Related]
3. Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.
Dirksen C; Bojsen-Møller KN; Jørgensen NB; Jacobsen SH; Kristiansen VB; Naver LS; Hansen DL; Worm D; Holst JJ; Madsbad S
Diabetologia; 2013 Dec; 56(12):2679-87. PubMed ID: 24048673
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
[TBL] [Abstract][Full Text] [Related]
5. Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.
Schmidt JB; Pedersen SD; Gregersen NT; Vestergaard L; Nielsen MS; Ritz C; Madsbad S; Worm D; Hansen DL; Clausen TR; Rehfeld JF; Astrup A; Holst JJ; Sjödin A
Int J Obes (Lond); 2016 Feb; 40(2):281-90. PubMed ID: 26303352
[TBL] [Abstract][Full Text] [Related]
6. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.
Bojsen-Møller KN; Dirksen C; Jørgensen NB; Jacobsen SH; Serup AK; Albers PH; Hansen DL; Worm D; Naver L; Kristiansen VB; Wojtaszewski JF; Kiens B; Holst JJ; Richter EA; Madsbad S
Diabetes; 2014 May; 63(5):1725-37. PubMed ID: 24241533
[TBL] [Abstract][Full Text] [Related]
7. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.
Jacobsen SH; Olesen SC; Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Worm D; Almdal T; Naver LS; Hvolris LE; Rehfeld JF; Wulff BS; Clausen TR; Hansen DL; Holst JJ; Madsbad S
Obes Surg; 2012 Jul; 22(7):1084-96. PubMed ID: 22359255
[TBL] [Abstract][Full Text] [Related]
8. Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.
Pop LM; Mari A; Zhao TJ; Mitchell L; Burgess S; Li X; Adams-Huet B; Lingvay I
Diabetes Obes Metab; 2018 Jul; 20(7):1710-1721. PubMed ID: 29532631
[TBL] [Abstract][Full Text] [Related]
9. Effects of gastric bypass surgery on insulin resistance and insulin secretion in nondiabetic obese patients.
Promintzer-Schifferl M; Prager G; Anderwald C; Mandl M; Esterbauer H; Shakeri-Leidenmühler S; Pacini G; Stadler M; Bischof MG; Ludvik B; Luger A; Krebs M
Obesity (Silver Spring); 2011 Jul; 19(7):1420-6. PubMed ID: 21494227
[TBL] [Abstract][Full Text] [Related]
10. Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects.
Salinari S; Bertuzzi A; Guidone C; Previti E; Rubino F; Mingrone G
Ann Surg; 2013 Mar; 257(3):462-8. PubMed ID: 23388352
[TBL] [Abstract][Full Text] [Related]
11. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes.
Kashyap SR; Daud S; Kelly KR; Gastaldelli A; Win H; Brethauer S; Kirwan JP; Schauer PR
Int J Obes (Lond); 2010 Mar; 34(3):462-71. PubMed ID: 20029383
[TBL] [Abstract][Full Text] [Related]
12. Updates in weight loss surgery and gastrointestinal peptides.
Svane MS; Bojsen-Møller KN; Madsbad S; Holst JJ
Curr Opin Endocrinol Diabetes Obes; 2015 Feb; 22(1):21-8. PubMed ID: 25517025
[TBL] [Abstract][Full Text] [Related]
13. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.
Rubino F; Gagner M; Gentileschi P; Kini S; Fukuyama S; Feng J; Diamond E
Ann Surg; 2004 Aug; 240(2):236-42. PubMed ID: 15273546
[TBL] [Abstract][Full Text] [Related]
14. Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus.
Qiu NC; Zhang Q; Song X; Liu ME; Li XK; Shan CX; Qiu M
J Surg Res; 2014 Sep; 191(1):123-9. PubMed ID: 24768143
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects.
Vidal J; Nicolau J; Romero F; Casamitjana R; Momblan D; Conget I; Morínigo R; Lacy AM
J Clin Endocrinol Metab; 2009 Mar; 94(3):884-91. PubMed ID: 19106269
[TBL] [Abstract][Full Text] [Related]
16. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
Seyfried F; Miras AD; Rotzinger L; Nordbeck A; Corteville C; Li JV; Schlegel N; Hankir M; Fenske W; Otto C; Jurowich C
Obes Surg; 2016 Jun; 26(6):1228-36. PubMed ID: 26377340
[TBL] [Abstract][Full Text] [Related]
17. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
[TBL] [Abstract][Full Text] [Related]
18. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
[TBL] [Abstract][Full Text] [Related]
20. Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.
Dirksen C; Jørgensen NB; Bojsen-Møller KN; Kielgast U; Jacobsen SH; Clausen TR; Worm D; Hartmann B; Rehfeld JF; Damgaard M; Madsen JL; Madsbad S; Holst JJ; Hansen DL
Int J Obes (Lond); 2013 Nov; 37(11):1452-9. PubMed ID: 23419600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
